Priligy at a Glance
Priligy 30 mg is a pharmaceutical preparation containing dapoxetine as the active ingredient, manufactured by Janssen-Cilag under license from Menarini. Dapoxetine is classified as a selective serotonin reuptake inhibitor (SSRI) with unique pharmacokinetic properties that make it valuable for laboratory research applications. This compound represents the first in its class specifically developed for rapid onset and short half-life characteristics, offering researchers at Stroid UK Shop an opportunity to examine selective serotonergic modulation mechanisms in controlled laboratory environments.
Laboratory Research Applications
Research scientists utilise dapoxetine preparations to investigate serotonin transporter (SERT) inhibition pathways and their downstream effects on cellular signalling cascades. The compound’s rapid absorption and elimination profile make it particularly suitable for time-sensitive experimental protocols examining acute serotonergic responses. Studies have examined dapoxetine’s interaction with various neurotransmitter systems, including its selectivity for serotonin versus norepinephrine and dopamine transporters. Researchers investigating dapoxetine mechanisms often combine these studies with other compounds from our SARMs collection or peptide research materials to examine complex pharmacological interactions in multi-target experimental designs.
Analytical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Dapoxetine hydrochloride |
| Strength | 30 mg per tablet |
| Manufacturer | Janssen-Cilag (Menarini) |
| CAS Number | 119356-77-3 (dapoxetine) |
| Molecular Formula | C₂₁H₂₃NO·HCl |
| Molecular Weight | 341.87 g/mol |
| Formulation | Film-coated tablets |
| Storage Conditions | Room temperature, dry environment |
Research Compliance Statement
This pharmaceutical preparation is supplied exclusively for legitimate laboratory research purposes and in-vitro analytical studies. Priligy 30 mg tablets are not intended for human consumption or therapeutic application. Researchers must ensure appropriate laboratory protocols, safety measures, and regulatory compliance when handling this material. All studies should be conducted under proper laboratory supervision with adequate documentation of experimental procedures and findings according to institutional research guidelines.
